December 5th, 2017
•Heterogeneous distribution of HER2-positive cells can be observed in a subset of breast cancers and generates clinical dilemmas. Here, we introduce a reliable and cost-effective protocol to define, quantify, and compare HER2 intra-tumor genetic heterogeneity in a large series of heterogeneously processed breast cancers.
Tags
Vídeos Relacionados
An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
High-throughput Gene Tagging in Trypanosoma brucei
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells
A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation
High-throughput Screening of Chemical Compounds to Elucidate Their Effects on Bacterial Persistence
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados